abrdn Life Sciences Investors (abrdn Life Sciences Investors) Equity-to-Asset

abrdn Life Sciences Investors Annual Data
	Trend	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
Equity-to-Asset				0.99	1.00	0.98	0.96	1.00

abrdn Life Sciences Investors Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Equity-to-Asset									0.98	0.97	0.96	0.98	1.00

For the Asset Management subindustry, abrdn Life Sciences Investors's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where abrdn Life Sciences Investors's Equity-to-Asset falls into.

abrdn Life Sciences Investors Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

abrdn Life Sciences Investors's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

abrdn Life Sciences Investors's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Life Sciences Investors  (NYSE:HQL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

abrdn Life Sciences Investors Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of abrdn Life Sciences Investors's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

abrdn Life Sciences Investors (abrdn Life Sciences Investors) Business Description